SARS-CoV-2 Spike protein (RBD, His & Avi Tag, CHO-expressed)
| Z03512 | |
|
|
|
|
|
|
| Ask us a question | |
IVD Raw Materials
| Z03512 | |
|
|
|
|
|
|
| Ask us a question | |
| Species | SARS-CoV-2 | ||||||
| Protein Construction |
|
||||||
| Purity | > 95% as analyzed by SDS-PAGE | ||||||
| Endotoxin Level | < 0.2 EU/μg of protein by gel clotting method | ||||||
| Biological Activity | SARS-CoV-2 Spike protein (RBD, Avi & His Tag, CHO-expressed) can bind with Human ACE2 (Cat. No.: Z03484) in functional ELISA assay. | ||||||
| Expression System | CHO | ||||||
| Theoretical Molecular Weight | 30 kDa | ||||||
| Formulation | Supplied as a solution in PBS pH 7.4 | ||||||
| Concentration | Please refer to the COA for the specific lot. | ||||||
| Storage & Stability | Upon receiving, this product remains stable for up to 6 months at -20°C or below. Avoid repeated freeze-thaw cycles. |
| Target Background | SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) also known as 2019-nCoV (2019 Novel Coronavirus) is a virus that causes illnesses ranging from the common cold to severe diseases. SARS-CoV-2 Spike Protein is composed of S1 domain and S2 domain. S1 contains a receptor-binding domain (RBD) that can specifically bind to angiotensin-converting enzyme 2 (ACE2), the receptor on target cells. It is believed that SARS-CoV-2 Spike Protein (RBD) has potential value for the diagnosis of the virus. |
| Synonyms | SARS-CoV-2 SP RBD; 2019-nCoV SP RBD |
For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.